Skip to main
CL
CL logo

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 29%
Hold 29%
Sell 7%
Strong Sell 0%

Bulls say

Colgate-Palmolive has demonstrated robust growth in its advertising expenditures, increasing from 11.6% of sales in 2021 to 13.5% in 2024, indicating a strategic focus on brand visibility and market penetration. The company has also effectively managed to grow both prices and volumes from the second quarter of 2023 through the third quarter of 2024, showcasing resilience in its sales strategy amidst market fluctuations. With approximately 70% of its business stemming from international markets, including 45% from emerging regions, Colgate-Palmolive is well-positioned to capitalize on expanding global consumer demand.

Bears say

Colgate-Palmolive experienced a gross margin decline of 75 basis points year-over-year in 2Q25, attributed to rising raw material costs and tariffs, which raises concerns about its operational efficiency. In addition, the company's sales volume has shown a downward trend, with declines of 0.3% in 1Q25 and 0.9% in 2Q25, despite achieving positive price growth during the same periods. Further complicating the outlook, the dog food category, which significantly contributes to revenue through Hill's brand, is witnessing an accelerating decline in U.S. retail channels, decreasing by 2.8% in 3Q25 year-to-date.

Colgate-Palmolive (CL) has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 29% recommend Buy, 29% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 14 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Dec 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $89.93, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $89.93, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.